Catalyst Wire Dossier Catalyst Wire Dossier

Romosozumab

romosozumab · Amgen
Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Romosozumab, covering 2018-11-08 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea [Phase 3]

See pricing